SEC Form 4 · accession 0001127602-15-000584
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon P Stonehouse
Officer — President & CEO · Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 5, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2015 | A | 28,400 | $0.00 | A | 670,540 | D | |
| Common StockF2 | Jan 1, 2015 | F | 5,652 | $12.16 | D | 664,888 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. In addition, the reporting person received an Annual Employee Option Grant of 135,700 non-qualified stock options. These options will vest upon the successful completion of various performance objectives not related to the Company's stock price and as such will be reported upon vesting.
- F2Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2013.